Orthofix Q2 sales spike 2.4% to $111.5M: 5 observations

Written by Mackenzie Garrity | August 07, 2018 | Print  |

Orthofix released its 2018 second quarter financial results.

Here are five observations:

1. For the second quarter, the company's sales topped $111.5 million, a 2.4 percent increase year-over-year.

2. Orthofix's spine fixation business segment generated $23.9 million in sales, an 11.8 percent increase year-over-year.

3. Within its biologics segment, Orthofix reported $17.7 million in sales, a 6.3 percent decrease year-over-year.

4. Orthofix reported $24.8 million in sales for its extremity fixation segment, a 0.2 percent increase year-over-year.

5. The company predicts its full-year sales to range between $450 million to $456 million.

To view the full financial report, click here.

More articles on devices and implants:
Fuse Medical completes Maxim Surgical acquisition
Alphatec sets sights on 12 new product launches: 3 things to know about the rest of the year
Zimmer Biomet names 2 industry veterans to board of directors — 4 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers